Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration - Genetic Engineering & Biotechnology News

Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration  Genetic Engineering & Biotechnology News

Eli Lilly will partner with ImmuNext to study and develop a preclinical novel potential target for autoimmune disease treatments, the companies said, through an ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases